Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Metabolically Benign Obesity

glucose, (beta-d)-isomer has been researched along with Metabolically Benign Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Agarwal, A; Ayers, CR; Jin, E; Khan, SS; Neeland, IJ1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Metabolically Benign Obesity

ArticleYear
Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.
    Mayo Clinic proceedings, 2021, Volume: 96, Issue:8

    Topics: Adult; Benzhydryl Compounds; Biomarkers; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Ischemia; Obesity, Metabolically Benign; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Troponin

2021